Literature DB >> 26459688

Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder.

Jan Rusz1, Jan Hlavnička2, Tereza Tykalová2, Jitka Bušková3, Olga Ulmanová4, Evžen Růžička4, Karel Šonka4.   

Abstract

OBJECTIVE: Patients with idiopathic rapid eye movement sleep behaviour disorder (RBD) are at substantial risk for developing Parkinson's disease (PD) or related neurodegenerative disorders. Speech is an important indicator of motor function and movement coordination, and therefore may be an extremely sensitive early marker of changes due to prodromal neurodegeneration.
METHODS: Speech data were acquired from 16 RBD subjects and 16 age- and sex-matched healthy control subjects. Objective acoustic assessment of 15 speech dimensions representing various phonatory, articulatory, and prosodic deviations was performed. Statistical models were applied to characterise speech disorders in RBD and to estimate sensitivity and specificity in differentiating between RBD and control subjects.
RESULTS: Some form of speech impairment was revealed in 88% of RBD subjects. Articulatory deficits were the most prominent findings in RBD. In comparison to controls, the RBD group showed significant alterations in irregular alternating motion rates (p = 0.009) and articulatory decay (p = 0.01). The combination of four distinctive speech dimensions, including aperiodicity, irregular alternating motion rates, articulatory decay, and dysfluency, led to 96% sensitivity and 79% specificity in discriminating between RBD and control subjects. Speech impairment was significantly more pronounced in RBD subjects with the motor score of the Unified Parkinson's Disease Rating Scale greater than 4 points when compared to other RBD individuals.
CONCLUSION: Simple quantitative speech motor measures may be suitable for the reliable detection of prodromal neurodegeneration in subjects with RBD, and therefore may provide important outcomes for future therapy trials.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acoustic analyses; Dysarthria; Parkinson's disease; Parkinsonism; Speech and voice disorders

Mesh:

Year:  2015        PMID: 26459688     DOI: 10.1016/j.sleep.2015.07.030

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  14 in total

1.  Developing a large scale population screening tool for the assessment of Parkinson's disease using telephone-quality voice.

Authors:  Siddharth Arora; Ladan Baghai-Ravary; Athanasios Tsanas
Journal:  J Acoust Soc Am       Date:  2019-05       Impact factor: 1.840

Review 2.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

Review 3.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

4.  Automated Detection of Parkinson's Disease Based on Multiple Types of Sustained Phonations Using Linear Discriminant Analysis and Genetically Optimized Neural Network.

Authors:  Liaqat Ali; Ce Zhu; Zhonghao Zhang; Yipeng Liu
Journal:  IEEE J Transl Eng Health Med       Date:  2019-10-07       Impact factor: 3.316

Review 5.  Motor Dysfunction in REM Sleep Behavior Disorder: A Rehabilitation Framework for Prodromal Synucleinopathy.

Authors:  Rebekah L S Summers; Miriam R Rafferty; Michael J Howell; Colum D MacKinnon
Journal:  Neurorehabil Neural Repair       Date:  2021-05-12       Impact factor: 3.919

6.  HiCommunication as a novel speech and communication treatment for Parkinson's disease: A feasibility study.

Authors:  Ellika Schalling; Helena Winkler; Erika Franzén
Journal:  Brain Behav       Date:  2021-05-04       Impact factor: 2.708

7.  Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease.

Authors:  Jan Rusz; Jan Hlavnička; Michal Novotný; Tereza Tykalová; Amelie Pelletier; Jacques Montplaisir; Jean-Francois Gagnon; Petr Dušek; Andrea Galbiati; Sara Marelli; Paul C Timm; Luke N Teigen; Annette Janzen; Mahboubeh Habibi; Ambra Stefani; Evi Holzknecht; Klaus Seppi; Elisa Evangelista; Anna Laura Rassu; Yves Dauvilliers; Birgit Högl; Wolfgang Oertel; Erik K St Louis; Luigi Ferini-Strambi; Evžen Růžička; Ronald B Postuma; Karel Šonka
Journal:  Ann Neurol       Date:  2021-05-07       Impact factor: 10.422

8.  Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder.

Authors:  Jan Hlavnička; Roman Čmejla; Tereza Tykalová; Karel Šonka; Evžen Růžička; Jan Rusz
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

Review 9.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

10.  Detecting Effect of Levodopa in Parkinson's Disease Patients Using Sustained Phonemes.

Authors:  Nemuel D Pah; Mohammod A Motin; Peter Kempster; Dinesh K Kumar
Journal:  IEEE J Transl Eng Health Med       Date:  2021-03-17       Impact factor: 3.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.